Ocugen Appoints Dr. Mohamed Genead as Chair of Retina Scientific Advisory Board
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases, today announced the appointment of …
Read More